Published in Antimicrob Agents Chemother on November 01, 1977
Comparative pharmacokinetics of Sch 28191 and amphotericin B in mice, rats, dogs, and cynomolgus monkeys. Antimicrob Agents Chemother (1984) 1.31
Pharmacokinetics of amphotericin B and flucytosine. Postgrad Med J (1979) 0.96
Comparative susceptibility of four kinds of pathogenic fungi to amphotericin B and amphotericin B methyl ester. Antimicrob Agents Chemother (1978) 0.91
Comparative neurotoxicities of amphotericin B and its mono-methyl ester derivative in rats. Antimicrob Agents Chemother (1993) 0.80
Therapy of fungal infections. Bull N Y Acad Med (1982) 0.75
A pharmacologic guide to the clinical use of amphotericin B. J Infect Dis (1969) 5.58
Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion. J Pharm Sci (1970) 5.21
Amphotericin B serum concentrations during therapy. Appl Microbiol (1970) 2.66
Experience with amphotericin B for the treatment of systemic mycoses. AMA Arch Intern Med (1958) 2.52
Coccidioidomycosis and its treatment with amphotericin B. Am J Med (1958) 2.44
Amphotericin B and other polyenic antifungal antibiotics. Am J Clin Pathol (1969) 2.07
Some aspects of the absorption, distribution, and excretion of amphotericin B in man. Antibiotic Med Clin Ther (New York) (1958) 2.04
Polyene macrolide derivatives. I. N-acylation and esterification reactions with amphotericin B. J Antibiot (Tokyo) (1972) 1.77
COMPARATIVE RESPONSES OF MAMMALIAN ERYTHROCYTES AND MICROBIAL PROTOPLASTS TO POLYENE ANTIBIOTICS AND VITAMIN A. Arch Biochem Biophys (1963) 1.73
Amphotericin B methyl ester hydrochloride and amphotericin B: comparative acute toxicity. Science (1973) 1.73
Biologically active N-acyl derivatives of polyene macrolide antifungal antibiotics. Antibiot Chemother (Northfield) (1961) 1.68
Polyene macrolide derivatives. II. Physical-chemical properties of polyene macrolide esters and their water soluble salts. J Antibiot (Tokyo) (1972) 1.52
The use of amphotericin B in man. JAMA (1962) 1.52
Comparison of amphotericin B and amphotericin B methyl ester: efficacy in murine coccidioidomycosis and toxicity. J Infect Dis (1976) 1.52
Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole. J Infect Dis (1975) 1.50
Polyene macrolide derivatives. 3. Biological properties of polyene macrolide ester salts. J Antibiot (Tokyo) (1972) 1.47
Amphotericin B therapy in an anephric patient. Antimicrob Agents Chemother (1973) 1.38
Comparative in vitro antifungal activity of amphotericin B and amphotericin B methyl ester. Antimicrob Agents Chemother (1975) 1.36
Comparative toxicological studies of amphotericin B methyl ester and amphotericin B in mice, rats, and dogs. Antimicrob Agents Chemother (1976) 1.27
Increased permeability of human erythrocytes induced by amphotericin B. J Infect Dis (1971) 1.25
Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice. J Infect Dis (1976) 1.21
Alternate-day amphotericin B therapy in the treatment of rhinocerebral phycomycosis (mucormycosis). Ann Intern Med (1968) 1.21
Water-soluble N-acetyl derivatives of heptaene macrolide antifungal antibiotics: microbiological studies. Antibiot Chemother (Northfield) (1961) 1.15
Current status of amphotericin B in the treatment of the systemic fungus infections. J Chronic Dis (1959) 1.14
Selective membrane toxicity of the polyene antibiotics: studies on natural membranes. Antimicrob Agents Chemother (1973) 1.09
Selective toxicity of the polyene antibiotics and their methyl ester derivatives. Biochem Biophys Res Commun (1977) 1.01
Some considerations as to the determination and significance of biologic half-life. J Pharm Sci (1971) 1.01
Studies on the absorption, distribution and excretion of radioactivity after intravenous and intraperitoneal administration of 14C-methyl ester of amphotericin B. J Antibiot (Tokyo) (1975) 0.91
Drug treatment of the systemic mycoses. Semin Drug Treat (1972) 0.91
Toxicity of amphotericin B and its methyl ester toward normal and tumor cell lines. Cancer Res (1975) 0.89
Synthesis and biological properties of alkyl esters of polyene antibiotics. J Pharm Sci (1975) 0.87
Use of statistical methods in evaluation of in vivo performance of dosage forms. J Pharm Sci (1973) 0.78
[Hemolytic study of amphotericin B]. Chiryo (1962) 0.77
Metachromatic agar-diffusion methods for detecting staphylococcal nuclease activity. Appl Microbiol (1971) 10.60
Obfuscation of the activity of antifungal antimicrobics by culture media. J Infect Dis (1972) 7.47
Nuclease production and lysostaphin susceptibility of Staphylococcus aureus and other catalase-positive cocci. Appl Microbiol (1971) 3.40
Gentamicin therapy in renal failure: a nomogram for dosage. Ann Intern Med (1972) 2.43
Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester. J Infect Dis (1976) 2.31
Diagnostic usefulness and safety of transtracheal aspiration. N Engl J Med (1967) 2.23
Susceptibility of three groups of Staphylococcus aureus to newer antimicrobial agents. Antimicrob Agents Chemother (1977) 2.09
An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. Science (1998) 1.93
Problems in the diagnosis and treatment of systemic candidiasis. J Infect Dis (1972) 1.83
Candicidin and other polyenic antifungal antibiotics. Bull World Health Organ (1965) 1.82
Miconazole therapy for coccidioidomycosis. JAMA (1974) 1.81
Polyene macrolide derivatives. I. N-acylation and esterification reactions with amphotericin B. J Antibiot (Tokyo) (1972) 1.77
Penetration of antimicrobial agents into bronchial secretions. Am J Med (1975) 1.74
Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol (1990) 1.57
Prediction of antimeningococcic chemoprophylactic efficacy. J Infect Dis (1971) 1.55
Polyene macrolide derivatives. II. Physical-chemical properties of polyene macrolide esters and their water soluble salts. J Antibiot (Tokyo) (1972) 1.52
Comparison of amphotericin B and amphotericin B methyl ester: efficacy in murine coccidioidomycosis and toxicity. J Infect Dis (1976) 1.52
Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole. J Infect Dis (1975) 1.50
Anti-viral activity of amphotericin B methyl ester: inhibition of HTLV-III replication in cell culture. Biochem Pharmacol (1986) 1.48
Polyene macrolide derivatives. 3. Biological properties of polyene macrolide ester salts. J Antibiot (Tokyo) (1972) 1.47
Effect of buffers on testing of Candida species susceptibility to flucytosine. J Clin Microbiol (1987) 1.44
The effect of polyene macrolides on the prostate gland and canine prostatic hyperplasia. Proc Natl Acad Sci U S A (1968) 1.43
Systemic zygomycosis caused by Apophysomyces elegans. J Med Vet Mycol (1986) 1.42
Chemotherapy of systemic fungal diseases. Annu Rev Pharmacol Toxicol (1978) 1.39
Development of resistance to 5-fluorocytosine in Candida parapsilosis during therapy. J Infect Dis (1974) 1.38
Experimental and clinical aspects of resistance determinants. Mode of resistance against beta-lactam antibiotics in staphylococci. Ann N Y Acad Sci (1971) 1.36
Gentamicin versus staphylococcus aureus. J Infect Dis (1969) 1.36
Disk agar diffusion susceptibility testing of yeasts. Antimicrob Agents Chemother (1978) 1.35
Comparative chemotherapeutic activity of amphotericin B and amphotericine B methy ester. Antimicrob Agents Chemother (1975) 1.35
Thermonuclease seroinhibition test for distinguishing Staphylococcus aureus from other coagulase-positive staphylococci. J Clin Microbiol (1979) 1.32
Synthetic medium for susceptibility testing. Antimicrob Agents Chemother (Bethesda) (1970) 1.31
Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole. J Clin Microbiol (1986) 1.30
An unusual outbreak of windborne coccidioidomycosis. N Engl J Med (1979) 1.27
Bacteriology of the lower respiratory tract as determined by fiber-optic bronchoscopy and transtracheal aspiration. J Infect Dis (1976) 1.23
Metachromatic agar-diffusion microslide technique for detecting staphylococcal nuclease in foods. Appl Microbiol (1972) 1.20
Nocardial brain abscess cured with cycloserine and sulfonamides. Am J Med Sci (1968) 1.20
Occurrence of protein A in Staphylococcus aureus and closely related Staphylococcus species. J Clin Microbiol (1979) 1.18
Stability of four antifungal antimicrobics in vitro. J Infect Dis (1978) 1.17
Effect of tetracycline, polymyxin B, and rifampin on phagocytosis. Clin Pharmacol Ther (1970) 1.17
Distribution of doubly radiolabelled amphotericin B methyl ester and amphotericin B in the non-human primate, Macaca mulatta. J Antimicrob Chemother (1980) 1.16
alpha-Phosphonosulfonic acids: potent and selective inhibitors of squalene synthase. J Med Chem (1996) 1.15
Studies on candicidin biogenesis. J Antibiot (Tokyo) (1972) 1.13
Separation of polyene antifungal antibiotics by high-speed liquid chromatography. J Chromatogr (1974) 1.11
Convenient assay for staphylococcal nuclease by the metachromatic well-agar-diffusion technique. Appl Microbiol (1972) 1.10
Treatment of open fractures: a prospective study. J Trauma (1983) 1.10
Polyene macrolide antibiotic amphotericin B. Crystal structure of the N-iodoacetyl derivative. J Am Chem Soc (1971) 1.10
Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections. Ann Intern Med (1977) 1.08
Cloning and characterization of a 3-N-aminoglycoside acetyltransferase gene, aac(3)-Ib, from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 1.07
In vitro antiherpetic activity of water-soluble amphotericin B methyl ester. Arch Virol (1975) 1.06
Susceptibility of "methicillin"-resistant Staphylococcus aureus to 12 antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1969) 1.05
Effect of nitrogen dioxide on pulmonary bacterial defense mechanisms. Arch Environ Health (1973) 1.05
Prostatic cholesterol metabolism: regulation and alteration. Prog Clin Biol Res (1981) 1.04
Infective endocarditis caused by Streptococcus bovis resistant to the lethal effect of penicillin G. Arch Intern Med (1978) 1.03
Tolerance of staphylococcal thermonuclease to stress. Appl Microbiol (1972) 1.03
The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor. Biochem Biophys Res Commun (1986) 1.02
Inhibition of HIV replication by liposomal encapsulated amphotericin B. Antiviral Res (1989) 1.01
Acquired and native resistance of Staphylococcus aureus to cephalexin and other beta-lactam antibiotics. Appl Microbiol (1970) 1.01
Induction of resistance in Staphylococcus aureus and Klebsiella pneumoniae by exposure to cephalothin and cefoxitin. J Infect Dis (1976) 1.00
The separation and differentiation of the gentamicin complex. J Chromatogr (1967) 0.99
Comparative acute toxicity of four drugs. A study of neomycin, gentamicin, kanamycin, and dihydrostreptomycin. Arch Intern Med (1967) 0.99
Dimeric half-molecules of human fibrinogen are joined through disulfide bonds in an antiparallel orientation. Biochemistry (1983) 0.98
Successful treatment of gram-negative bacillary meningitis with moxalactam. Ann Intern Med (1981) 0.98
The polymyxins. Med Clin North Am (1970) 0.97
Stability studies with amphotericin B and amphotericin B methyl ester. J Antibiot (Tokyo) (1975) 0.97
1,1-Bisphosphonate squalene synthase inhibitors: interplay between the isoprenoid subunit and the diphosphate surrogate. J Med Chem (1995) 0.97
Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children. Pediatr Infect Dis J (1996) 0.96
A survey of academic anesthesiology. Submitted by ASA Subcommittee (Task Force) on Academic Anesthesia Manpower. Anesthesiology (1977) 0.96
Coconut and Salmonella infection. Appl Microbiol (1967) 0.96
Polyene macrolide antibiotic cytotoxicity and membrane permeability alterations. I. Comparative effects of four classes of polyene macrolides on mammalian cells. J Cell Physiol (1978) 0.95
Grouping of gram-negative bacteria and susceptibility to antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1965) 0.94
In vitro activities of two new antifungal azoles. Antimicrob Agents Chemother (1984) 0.94
Postoperative infection of an aortic prosthesis with Achromobacter xylosoxidans. West J Med (1982) 0.94
Adverse influence of ozone on pulmonary bactericidal activity of murine lung. Nature (1971) 0.94
Hepatotoxicity and transaminase measurement during isoniazid chemoprophylaxis in children. Pediatr Infect Dis J (1995) 0.94
Hydroheptin: a water-soluble polyene macrolide. I. Taxonomy, fermentation and isolation. J Antibiot (Tokyo) (1979) 0.94
Susceptibility of staphylococci to new antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1967) 0.93
Lipophilic 1,1-bisphosphonates are potent squalene synthase inhibitors and orally active cholesterol lowering agents in vivo. J Biol Chem (1993) 0.93
Evidence for a role of the amino-terminal region in the biological activity of the classical anaphylatoxin, porcine C5a des-Arg-74. J Biol Chem (1985) 0.91
Providence bacillus bacteremia and septicopyemia. Am J Med (1968) 0.91
Comparative susceptibility of four kinds of pathogenic fungi to amphotericin B and amphotericin B methyl ester. Antimicrob Agents Chemother (1978) 0.91
Amoxicillin therapy of acute urinary infections in adults. Antimicrob Agents Chemother (1977) 0.91
Studies on the absorption, distribution and excretion of radioactivity after intravenous and intraperitoneal administration of 14C-methyl ester of amphotericin B. J Antibiot (Tokyo) (1975) 0.91
Purification of High Titer Tetanus Toxin. J Bacteriol (1945) 0.90
Reproducible method for induction of pulmonary coccidioidomycosis in mice. J Infect Dis (1977) 0.90
Toxicity of amphotericin B and its methyl ester toward normal and tumor cell lines. Cancer Res (1975) 0.89
In vitro susceptibilities of Naegleria fowleri strain HB-1 to selected antimicrobial agents, singly and in combination. Antimicrob Agents Chemother (1979) 0.88
The hypocholesterolemic activity of orally administered polyene macrolides. Proc Natl Acad Sci U S A (1968) 0.88
Fungimycin, biogenesis of its aromatic moiety. J Antibiot (Tokyo) (1972) 0.88
Ozone and the antibacterial defense mechanisms of the murine lung. Arch Intern Med (1971) 0.88
Recovery from encephalomyelitis caused by Herpesvirus simiae. Report of a case. Arch Intern Med (1975) 0.88
Parenteral sodium ampicillin therapy of endocarditis, salmonellosis, and other bacterial infections. Antimicrob Agents Chemother (Bethesda) (1965) 0.88
Acquisition of coccidioidomycosis at necropsy by inhalation of coccidioidal endospores. Diagn Microbiol Infect Dis (1992) 0.88
Feasibility of high-resolution, low-dose chest CT in evaluating the pediatric chest. Pediatr Radiol (1994) 0.87